Small Science,
Journal Year:
2024,
Volume and Issue:
4(3)
Published: Jan. 17, 2024
Despite
the
great
potential
of
cuproptosis
in
tumor
therapy,
current
cuproptosis‐based
therapy
still
suffers
from
compromised
efficiency
immune
activation.
Pyroptosis,
a
proinflammatory
cell
death
modality,
provides
good
opportunity
to
induce
immunogenic
(ICD)
and
promote
systemic
response.
However,
synergistic
pyroptosis
has
not
been
fully
explored.
Herein,
it
is
discovered
that
Cu(II)‐based
metal–organic
framework
(MOF)
nanoparticles
(NPs)
can
synergistically
evoke
ICD
for
high‐efficiency
tumor‐targeted
immunotherapy.
Although
MOF‐199
widely
used
immunogenicity
unclear.
Pluronic
F127‐modified
NPs
(
F127
NPs)
show
dual‐responsiveness
glutathione
(GSH)
hydrogen
sulfide
(H
2
S).
Once
entering
cancer
cells,
dissociate
GSH‐enriched
microenvironment
(TME)
release
copper
ion
copper‐overload‐mediated
cuproptosis.
Meanwhile,
transform
Cu
2−
x
S
by
situ
sulfidation
under
H
S‐enriched
colorectal
(CRC)
TME.
Under
photothermal
chemodynamic
(PTT/CDT)
NPs,
caspase‐3
activated
gasdermin
E
(GSDME)‐related
triggered.
The
have
proved
superior
antitumor
immunity
effect
both
vitro
vivo
experiments.
This
work
new
strategy
achieve
immunotherapy
with
high
simple
NPs.
Journal of the American Chemical Society,
Journal Year:
2024,
Volume and Issue:
146(20), P. 13805 - 13816
Published: March 29, 2024
Cuproptosis,
a
copper-dependent
cell
death
process,
has
been
confirmed
to
further
activate
the
immune
response
and
mediate
resistance.
However,
hypoxic
tumor
microenvironment
hampers
cuproptosis
sensitivity
suppresses
body's
antitumor
response.
Herein,
we
have
successfully
immobilized
functionalized
catalase
(CAT)
with
long
single-stranded
DNA
containing
polyvalent
CpG
sequences
through
rolling
circle
amplification
(RCA)
techniques,
obtaining
an
enzyme-cored
spherical
nucleic
acid
nanoplatform
(CAT-ecSNA-Cu)
deliver
copper
ions
for
cuproptosis.
The
presence
of
long-stranded
DNA-protected
CAT
enhances
mitochondrial
respiration
by
catalyzing
conversion
H2O2
O2,
thereby
sensitizing
Meanwhile,
increased
oxygenation
expression
hypoxia-inducible
factor-1
(HIF-1)
protein,
resulting
in
alleviation
immunosuppressive
microenvironment.
Of
note,
induces
immunogenic
(ICD),
which
facilitates
dendritic
(DC)
maturation
antigen
presentation
polyCpG-supported
Toll-like
receptor
9
(TLR9)
activation.
Furthermore,
cuproptosis-induced
PD-L1
upregulation
cells
complements
checkpoint
blockers
(αPD-L1),
enhancing
immunity.
strategy
cuproptosis-mediated
responses
alleviating
hypoxia
effectively
promotes
activation
proliferation
effector
T
cells,
ultimately
leading
long-term
immunity
against
cancer.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(15)
Published: Feb. 11, 2024
Abstract
Overproduction
of
reactive
oxygen
species
(ROS),
metal
ion
accumulation,
and
tricarboxylic
acid
cycle
collapse
are
crucial
factors
in
mitochondria‐mediated
cell
death.
However,
the
highly
adaptive
nature
damage‐repair
capabilities
malignant
tumors
strongly
limit
efficacy
treatments
based
on
a
single
treatment
mode.
To
address
this
challenge,
self‐reinforced
bimetallic
Mito‐Jammer
is
developed
by
incorporating
doxorubicin
(DOX)
calcium
peroxide
(CaO
2
)
into
hyaluronic
(HA)
‐modified
metal‐organic
frameworks
(MOF).
After
cellular,
dissociates
CaO
Cu
2+
tumor
microenvironment.
The
exposed
further
yields
hydrogen
(H
O
Ca
weakly
acidic
environment
to
strengthen
‐based
Fenton‐like
reaction.
Furthermore,
combination
chemodynamic
therapy
overload
exacerbates
ROS
storms
mitochondrial
damage,
resulting
downregulation
intracellular
adenosine
triphosphate
(ATP)
levels
blocking
Cu‐ATPase
sensitize
cuproptosis.
This
multilevel
interaction
strategy
also
activates
robust
immunogenic
death
suppresses
metastasis
simultaneously.
study
presents
multivariate
model
for
revolutionizing
mitochondria
relying
continuous
retention
ions
boost
cuproptosis/immunotherapy
cancer.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(18)
Published: Jan. 23, 2024
Abstract
Cuproptosis,
a
newly
discovered
cell
death
pathway,
has
shown
great
potential
in
cancer
treatment.
Herein,
near‐infrared
(NIR)
light‐driven
nanomotors
(CuSiO
3
@Au‐Pd
NMs)
are
designed
for
cuproptosis‐assisted
synergistic
therapy
with
autonomous
mobility
and
improved
cellular
uptake
tumor
penetration.
Specifically,
the
released
Cu
2+
ions
from
CuSiO
NMs
can
induce
Fenton‐like
reaction,
leading
to
generation
of
hydroxyl
radicals
(·OH),
accompanied
by
depletion
glutathione
within
MCF‐7
cells.
Additionally,
also
exhibit
excellent
photothermal
effects,
which
further
promote
production
·OH,
resulting
intensified
oxidative
stress
apoptosis.
Moreover,
enhanced
permeation
efficiency
via
movement
under
self‐thermophoretic
forces
proved
using
2D
experiments
3D
multicellular
spheroids.
The
resultant
intracellular
accumulation
oligomerization
lipoylated
proteins,
cuproptosis,
along
mitochondrial
dysfunction
pathway.
More
importantly,
both
vitro
vivo
show
that
could
penetrate
deeply
into
tumors
anticancer
efficacy
through
multimodal
therapeutic
methods.
These
findings
manifest
promising
potentials
NIR‐powered
Cu‐based
high
maneuverability
future
smart
therapy.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(12), P. 9031 - 9042
Published: March 12, 2024
Cuproptosis
has
drawn
enormous
attention
in
antitumor
material
fields;
however,
the
responsive
activation
of
cuproptosis
against
tumors
using
nanomaterials
with
high
atom
utilization
is
still
challenging.
Herein,
a
copper-based
nanoplatform
consisting
acid-degradable
copper
hydride
(CuH)
nanoparticles
was
developed
via
microfluidic
synthesis.
After
coating
tumor-targeting
hyaluronic
acid
(HA),
denoted
as
HA-CuH-PVP
(HCP)
shows
conspicuous
damage
toward
tumor
cells
by
generating
Cu+
and
hydrogen
(H2)
simultaneously.
can
induce
apoptosis
relying
on
Fenton-like
reactions
lead
to
causing
mitochondrial
protein
aggregation.
Besides,
existence
H2
enhance
both
cell
death
types
dysfunction
intracellular
redox
homeostatic
disorders.
In
vivo
experimental
results
further
exhibit
desirable
potential
HCP
for
killing
inhibiting
lung
metastases,
which
will
broaden
horizons
designing
materials
triggering
better
efficacy.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(37)
Published: April 25, 2024
Abstract
Cuproptosis
and
ferroptosis
hold
great
promise
for
overcoming
apoptotic
resistance
in
liver
cancer
based
on
their
unique
metal‐driven
cell
death
modalities.
However,
insufficient
intracellular
copper
iron
concentration,
complicated
tumor
microenvironment
(TME),
unclear
cross‐regulatory
mechanisms
between
cuproptosis
ferroptosis,
severely
restrict
the
therapeutic
performance.
Herein,
copper‐doped
hollow
Prussian
blue
(CHP)
nanozymes
are
rationally
designed
loading
photosensitizer
indocyanine
green
(ICG)
O
2
‐saturated
perfluorohexane
(PFH),
denoted
as
‐PFH@CHPI
nanoparticles,
to
induce
ferroptosis.
In
response
specific
TME,
CHP
can
synergistically
catalyze
Fenton
reactions
consume
endogenous
glutathione,
leading
accumulation
of
reactive
oxygen
species.
Upon
near‐infrared
irradiation,
‐PFH@CHPI‐enabled
photothermal
effect
simultaneously
accelerate
catalytic
trigger
release
photodynamic
therapy
promote
oxidative
stress.
Notably,
be
effectively
activated
through
Cu
+
‐mediated
dihydrolipoamide
S‐acetyltransferase
aggregation
Fe–S
cluster
protein
loss.
Concurrently,
tilt
redox
balance
is
favorable
lipid
peroxidation
glutathione
peroxidase
4
inactivation,
resulting
an
augmented
effect.
Mechanistically,
stress‐boosted
jointly
disrupt
mitochondrial
metabolism,
which
turn
exacerbates
stress,
thus
realizing
a
mutually
enhanced
This
work
may
provide
new
guidance
utilizing
copper/ferrous‐engineering
cuproptosis/ferroptosis
synergetic
therapy.
Chemistry of Materials,
Journal Year:
2024,
Volume and Issue:
36(2), P. 815 - 828
Published: Jan. 11, 2024
Cuproptosis
is
a
newly
identified
copper-dependent
cell
death
and
holds
great
promise
for
cancer
therapy.
However,
transporting
enough
copper
into
cells
challenge.
Herein,
an
intelligent
cupreous
nanoplatform
(denoted
as
CuO2-MSN@TA-Cu2+),
consisting
of
in
situ
formation
CuO2
within
mesoporous
silica
nanoparticles
(MSN)
then
deposition
with
tannic
acid
(TA)-Cu2+
complex,
designed
developed
to
realize
on-demand
delivery
cuproptosis-based
combination
CuO2-MSN@TA-Cu2+
exhibits
tumor
microenvironment-triggered
therapeutic
activity,
wherein
the
outer
TA-Cu2+
complex
readily
disassembled
release
Cu2+
liberate
internal
produce
H2O2.
The
overloaded
can
not
only
directly
convert
endogenous
H2O2
self-supplied
highly
toxic
hydroxyl
radicals
chemodynamic
therapy
(CDT)
via
Cu-based
Fenton-like
reaction
but
also
undergo
glutathione-mediated
reduction
Cu+
species
induce
potent
cellular
cuproptosis
enhance
CDT.
experimental
results
indicate
that
produces
remarkable
cytotoxicity
against
significantly
suppresses
growth
by
93.42%
mice-bearing
4T1
breast
tumors.
This
work
provides
new
paradigm
boost
cuproptosis-related
may
inspire
design
advanced
nanoplatforms.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(18)
Published: March 26, 2024
Cuproptosis
is
dependent
on
mitochondrial
respiration
modulation
by
targeting
lipoylated
tricarboxylic
acid
cycle
(TCA)
proteins,
showing
great
potential
in
cancer
treatment.
However,
the
specific
release
of
copper
ions
at
highly
needed
and
still
a
major
challenge
to
trigger
cellular
cuproptosis.
Herein,
metal-organic
framework-based
nanoplatform
(ZCProP)
designed
for
mitochondrial-targeted
ATP/pH-responsive
Cu